Roluperidone FDA Approval Status
FDA Approved: No
Generic name: roluperidone
Company: Minerva Neurosciences, Inc.
Treatment for: Schizophrenia
Roluperidone is a 5-HT2A and sigma2 receptor antagonist in development for the treatment of certain symptoms in patients with schizophrenia.
Development timeline for roluperidone
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.